← Back to patent-cliff list
CAS 218457-67-1
3-Pyridinamine, 6-[4-(1,1-dimethylethyl)phenoxy]-
Codes: CB-103
Application context (from source-drug indications)
Adenoid cystic carcinomaLimantrafinLeukaemiaLimantrafinAcute lymphoblastic leukaemiaLimantrafinBreast cancerLimantrafinSolid tumourLimantrafinHaematological malignancyLimantrafin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Limantrafin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(tert-butyl)phenol→2-chloro-5-nitropyridine→2-(4-(tert-butyl)phenoxy)-5-nitropyridine→3-Pyridinamine, 6-[4-(1,1-dimethylethyl)phenoxy]-
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.